Director’s Blog When Secretary of State Hillary Clinton visited NIH last November , she spoke of an “AIDS-free generation” and the promise of research to achieve this goal. AIDS is an infectious disease, and not surprisingly, most NIH AIDS research is supported by NIAID. But the AIDS epidemic is driven by behavior, so NIMH has been an important part of the NIH fight against HIV/AIDS for over two decades.

Read >

Director’s Blog About a decade ago NIH held a series of workshops to develop a Roadmap for Biomedical Research. We brought experts to Bethesda to suggest new directions for technology development, training, and a range of other areas. In one such meeting, on re-engineering clinical research, many of the nation’s leading clinical scientists debated how to improve our approach to research on diseases.

Read >

Abstract: Objective: Physician suicide is an important public health problem as the rate of suicide is higher among physicians than the general population. Unfortunately, few studies have evaluated information about mental health comorbidities and psychosocial stressors which may contribute to physician suicide.

Read >

Director’s Blog Every year the Interagency Autism Coordinating Committee (IACC) updates its Strategic Plan for Autism Spectrum Disorder Research , identifying progress and new opportunities across the range of autism spectrum disorder (ASD) research. Each year this task gets more difficult. In 2012, the speed of progress was so rapid that each draft of the Plan was out of date by the time the IACC reviewed it.

Read >

Director’s Blog In a commentary just published on innovation in health care, Narayan and colleagues describe the need for integrated solutions to mental health care. 1 Moving beyond “magic bullets” and the magical thinking of a single intervention for a complex problem, they recommend a comprehensive model that includes early detection, better access to care, monitoring, and patient-reported outcomes. None of this would be particularly innovative, except that Narayan and his colleagues all work for a pharmaceutical company.

Read >